These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 879127)

  • 41. Flucloxacillin-associated hepatic injury.
    Koek GH; Stricker BH; Blok AP; Schalm SW; Desmet VJ
    Liver; 1994 Oct; 14(5):225-9. PubMed ID: 7997079
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug-induced hepatitis with hepatic granuloma due to saridon.
    Abe M; Kumagi T; Nakanishi S; Yamagami T; Michitaka K; Abe K; Okura I; Yamashita H; Horiike N; Onji M
    J Gastroenterol; 2002; 37(12):1068-72. PubMed ID: 12522541
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute cholestatic hepatitis associated with pravastatin.
    Hartleb M; Rymarczyk G; Januszewski K
    Am J Gastroenterol; 1999 May; 94(5):1388-90. PubMed ID: 10235223
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phenytoin-induced toxic cholestatic hepatitis in a patient with skin lesions: case report.
    Altuntaş Y; Oztürk B; Erdem L; Günes G; Karul S; Uçak S; Sengül A
    South Med J; 2003 Feb; 96(2):201-3. PubMed ID: 12630649
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Terbinafine-induced cholestatic liver injury].
    Shiloah E; Horowiz M; Zecler E
    Harefuah; 1997 Jul; 133(1-2):11-2, 80-1. PubMed ID: 9332048
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Committee on the Review of Medicines. Recommendations on phenylbutazone, oxyphenbutazone, feprazone, allopurinol, colchicine, probenecid, and sulphinpyrazone.
    Br Med J; 1978 Jun; 1(6125):1466-7. PubMed ID: 306273
    [No Abstract]   [Full Text] [Related]  

  • 47. Granulomatous liver disease and cholestasis.
    Matheus T; Muñoz S
    Clin Liver Dis; 2004 Feb; 8(1):229-46, ix. PubMed ID: 15062203
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanisms and prediction of drug-induced liver disease.
    Berthelot P
    Gut; 1973 Apr; 14(4):332-9. PubMed ID: 4574904
    [No Abstract]   [Full Text] [Related]  

  • 49. Hydralazine-induced cholestatic hepatitis.
    Hassan A; Hammad R; Cucco R; Niranjan S
    Am J Ther; 2009; 16(4):371-3. PubMed ID: 19092641
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Hepatic cholestasis following Benetazone (proceedings)].
    Krtek V; Chlumský J
    Cesk Gastroenterol Vyz; 1978 Dec; 32(8):536. PubMed ID: 570096
    [No Abstract]   [Full Text] [Related]  

  • 51. Clinical and histologic features of Azathioprine-induced hepatotoxicity.
    Siramolpiwat S; Sakonlaya D
    Scand J Gastroenterol; 2017 Aug; 52(8):876-880. PubMed ID: 28388864
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Generalized pustular psoriasis precipitated by phenylbutazone and oxyphenbutazone.
    Reshad H; Hargreaves GK; Vickers CF
    Br J Dermatol; 1983 Jul; 109(1):111-3. PubMed ID: 6860567
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ticlopidine-induced cholestatic hepatitis with anti-nuclear antibody in serum.
    Tsai MH; Tsai SL; Chen TC; Liaw YF
    J Formos Med Assoc; 2000 Nov; 99(11):866-9. PubMed ID: 11155780
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Non-steroidal antirheumatic therapy and the liver].
    Frank O
    Acta Med Austriaca; 1975; 2(4):145-8. PubMed ID: 1224930
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Contact sensitivity to oxyphenbutazone (Tanderil) and cross-sensitivity to phenylbutazone (Butazolidin).
    Krook G
    Contact Dermatitis; 1975 Aug; 1(4):262. PubMed ID: 139243
    [No Abstract]   [Full Text] [Related]  

  • 56. [Toxic liver injury].
    Bode C; Martini GA
    Med Klin; 1970 Jan; 65(1):8-16. PubMed ID: 4926626
    [No Abstract]   [Full Text] [Related]  

  • 57. Drug-induced chronic hepatitis.
    Wright R
    Springer Semin Immunopathol; 1980 Dec; 3(3):331-8. PubMed ID: 7022714
    [No Abstract]   [Full Text] [Related]  

  • 58. Therapeutic hazards of phenylbutazone and oxyphenbutazone in polymyalgia rheumatica.
    Wadman B; Werner I
    Lancet; 1967 Mar; 1(7490):597-8. PubMed ID: 4163976
    [No Abstract]   [Full Text] [Related]  

  • 59. [Morphology and pathogenesis of liver injury produced by dihydralazine , propranolol and ketophenylbutazone].
    Kunze KD; Porst H; Tschöpel L
    Zentralbl Allg Pathol; 1985; 130(6):509-18. PubMed ID: 3841742
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prolonged jaundice following ketoconazole-induced hepatic injury.
    Benson GD; Anderson PK; Combes B; Ishak KG
    Dig Dis Sci; 1988 Feb; 33(2):240-6. PubMed ID: 3338372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.